Since the two oligopeptides specific for EGFR and HER2 were involved in the fusion protein Ec-LDP-Hr-AE, it was likely bound to tumor cells overexpressing both receptors instead of normal cells with low expression of one or both receptors. This evidence concerns the gene EGFR and neoplasm.